Pharmafile Logo
Pharmafocus logo
Advanced Search

Press release

Showing 15 posts of 581 posts found.

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for Pegunigalsidase Alfa for Treatment of Fabry Disease

March 3, 2023
Business Services

Manchester, UK, 3rd March 2023 – Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver …

News
Press release

Globesity: the silent pandemic of the 21st century. Multidisciplinary and new incisionless endoscopic technique may be an effective solution for adult patients.

March 3, 2023
Business Services

London, 03/03/2023- Ahmed is 45 years old and weighed 120 kg. He was always very tired, and would even fall …

News
Press release

Positive Results from POLB 001 LPS Human Challenge Trial

March 2, 2023
Business Services

Key Highlights

News
Press release

Menopause Action Plan – How nutritional support can keep female employees at work

March 1, 2023
Business Services

Through simple nutrition and lifestyle changes HR managers could enable women to continue to thrive at work and pursue their …

News
Press release

Ten new companies enter BioInnovation Institute’s Venture Lab program

March 1, 2023
Business Services

COPENHAGEN, Denmark, March 1, 2023 – BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, today …

News
Press release

PureTech to Present at the Barclays Global Healthcare Conference

March 1, 2023
Business Services

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the treatment …

News
Press release

Industrywide Survey Reveals Centralising Regulatory is Number One Priority for Medtech

March 1, 2023
Business Services

BARCELONA, Spain — 28 Feb. 2023 — New research shows a majority of medtech organizations are taking action to advance …

News
Press release

Ascelia Pharma meets major milestone with patient enrollment completion of Phase 3 Study for Orviglance, novel MRI contrast agent for patients with kidney impairment

February 28, 2023
Business Services

Ascelia Pharma AB (publ) (ticker: ACE), a biotech focused on improving the life of people living with rare cancer conditions, …

News
Press release

Rare and orphan disease expert Terebellum launches market access guide

February 28, 2023
Business Services

Terebellum, subsidiary of global specialty pharmacy and healthcare solutions organisation AscellaHealth, is launching a strategic guide to help manufacturers bring …

News
Press release

Rare disease community call for their unified voice to be heard in the fight for equitable care

February 28, 2023
Business Services

Reading, 28th February 2023.

News
Press release

PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)

February 27, 2023
Business Services

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded …

News
Press release

Almirall opens the doors of its R&D centre to the biotech ZeClinics

February 27, 2023
Business Services

BARCELONA, Spain. February 27th 2023 – Almirall, a global biopharmaceutical company focused on skin health, today announced an agreement with …

News
Press release

HUTCHMED Completes Patient Enrollment of Phase II Registration Trial of Amdizalisib in Follicular Lymphoma in China

February 27, 2023
Business Services

Hong Kong, Shanghai & Florham Park, NJ — Monday, February 27, 2023: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM, HKEX:​13) today announces …

News
Press release

CN Bio extends microphysiological system portfolio with PhysioMimix Single-Organ Higher Throughput System

February 27, 2023
Business Services

Cambridge, UK, 27 February 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems …

News
Press release

Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment

February 27, 2023
Business Services

Cambridge, UK, 27 February 2023: Five Alarm Bio (FAB), a drug discovery company focused on novel approaches to anti-aging, announced …

News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025